Navigation Links
Drug Firm on the Threshold of Developing Dengue Vaccine

A giant pharmaceutical firm is close to developing the world's first vaccine against dengue fever as Singapore and neighbouring countries battle outbreaks, a news report said Friday.

Clinical tests on up to 3,000 people will begin by early next year in Thailand, said Jean Stephenne, GlaxoSmithKline Biologicals president.

"We've been working on the dengue vaccine with the US Army for 10 years, more or less," The Straits Times quoted Stephenne as saying.

The Thai trials will be part of the second phase of the process.

The vaccine was tested on 500 people in the United States during the first phase and proved safe and effective, Stephenne said. Once the Thai trials are completed, the vaccine will move to the final stage to test its effectiveness in other parts of the world, including Singapore.

Cases of the Aedes mosquito-carried virus have reached epidemic levels twice in the city-state since June. There have been 3,597 cases and three deaths since the start of the year.

Intermittent rain and warm weather have been blamed for the onslaught of mosquito breeding.

Stephenne said that another key factor is that the virus has four variations.

"We have to prove the vaccine will be safe for everyone, which means both children and adults," Stephenne told the newspaper.

The company is aiming to have the vaccine on the market in about five years. By that time, Stephenne estimates that between $500 million to $1 billion will have been spent on research and development.


'"/>




Page: 1

Related medicine news :

1. Calcium Supplements May Not Be Useful After A Certain Threshold Is Achieved
2. Risk Of Developing Arthritis
3. Developing HIV fighter
4. Antibiotics Found To Increase The Risk Of Developing Breast Cancer
5. The Effectiveness Of Cancer Drug In Women At Risk Of Developing Cancer
6. Men Who at Risk Of Developing Prostate Cancer
7. Identifying The Risks Of Developing Schizophrenia
8. Patients With Severe Hemophilia At Risk Of Developing Osteoporosis
9. Cancer Patients At A Greater Risk Of Developing Blood Clots
10. Young Smokers at Increased Risk Of Developing a Heart Attack
11. Women With Diabetes At Increased Risk Of Developing Cognitive Impairment

Post Your Comments:
(Date:11/27/2009)...Replikins Ltd. today issued its latest biochemical...s that the lethality of the virus has dropped from...rent outbreak in the spring of 2009 to resting non...H1N1 infectivity count, however, remains increased...er 27, 2009 -- Biotech firm Replikins Ltd., which ...
(Date:11/27/2009)...wswire-FirstCall/ -- The Gymboree Corporation (Nas..., will present at the NASDAQ OMX 23rd Investor Pro...London, England, on Wednesday, December 2, 2009, a...ast of The Gymboree Corporation,s presentation ove... click on "Our Company" at the bottom of the page,...
(Date:11/27/2009)..., Nov. 27 Team Garmin-Slipstream, ...ated to ethical sporting and developing the next g...at it will become Team Garmin-Transitions with the...of the team. Transitions Optical is the world,s le...he most advanced photochromic technology in the wi...
(Date:11/27/2009)...ings has announced that it has become a national s...gest nonprofit organizations dedicated to arthriti... Delray Beach, FL (Vocus) November..., a company specializing in the marketing and reta...as announced today that is has become a national s...
(Date:11/27/2009)...dical, economic burdens, study predicts , ... of people with diabetes in the United States is e...udy predicts. , That would bring the total by 2... up from 23.7 million today. , , At the same tim...triple, the study also warns, rising from an estim...
Breaking Medicine News(10 mins):Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3
...umer group has petitioned the Food and Drug Admini...mine. Public Citizen says the drug, sold as Meridi...// cardiovascular causes such as heart attacks. Bu...any diseases and premature death. This is not...
...ing to a study, siblings of people with Alzheimer'...dementia.// More than half of patients with Alzhei...hallucinations and delusions. This is an especiall...at the Alzheimer's disease Research Center in Dall...
...toid arthritis strikes about 1 percent of people, ...d to die about 10 years sooner than normal. It is ...cause// of the wear-and-tear of aging. It occurs w... to an increased risk of heart disease. Metho...
...mer's is a degenerative brain disease that usually...nt events or familiar tasks. The disease eventuall...hanges and impaired judgment. Communication become...ople with Alzheimer’s disease become unable to car...
...ing to Dr. John Poll, curing a laborious birth def...ely bulging eyes, sliced apart all the bones of he...p.// Instead, 10-year-old Alyssa got a promising a..., slowly pulling out the sunken bones so they coul...
...n has been a pain-reliever for more than 100 years...he 19th century have been abandoned, the use of as...uce pain, fever, inflammation, prevent blood clots...ered, relatively few drugs have been developed tha...
Other Medicine News:Health News:Surgery-Rigged pulley helps patients 2
(Date:11/25/2009)...5 Heska Corporation ( HS...iagnostic and specialty products to the veterinary...iagnostics Corporation for the supply of blood gas...inary market. ,, (Logo: http://www.newscom...a and Roche share the same passion for innovating ...
(Date:11/25/2009)...wswire/ -- BioTrends Research Group, Inc. released...eport, the first in a multi-phase syndicated marke... Ortho-Biotech,s Stelara, from product launch thro...ve of the report provides quantitative information...ormation from a subset of 20. The reports assess ...
(Date:11/25/2009)... 25 Regado Biosciences, a privatel...mbotic aptamers with active control agents, announ... be presenting at the Piper Jaffray 21st Annual He...in New York City. Dr. Mazzo,s presentation will b... will include an overview of the Company,s pipelin...
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Alexza Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference 13917 1Alexza Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference 13917 2Alexza Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference 13917 350 Millionth Unique Chemical Substance Recorded in CAS REGISTRY 28SM 29 56488 150 Millionth Unique Chemical Substance Recorded in CAS REGISTRY 28SM 29 56488 250 Millionth Unique Chemical Substance Recorded in CAS REGISTRY 28SM 29 56488 3FDA pharmaceutical import alert 56486 1
...sdaq: DNDN ) today announced that it expects the ...view in October 2008 the interim analysis,of overa...CT (IMmunotherapy,for Prostate AdenoCarcinoma Trea...VENGE(R) (sipuleucel-T). PROVENGE is the Company,s... the treatment of advanced prostate,cancer. Should...
...ter 293-patient European, trial -, http://www.c... MONTREAL, July 22 /PRNewswire-FirstCall/ - CryoC...otherapy products to treat cardiac,arrhythmias, to...om three,European study centers using the Company,...lier today in the Journal of the American College ...
Other Medicine Technology:Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 3
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
Medicine Products: